Mathai Mammen - Feb 14, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Pharm, R&D
Signature
Raavi Deol, as attorney-in-fact for Mathai Mammen
Stock symbol
JNJ
Transactions as of
Feb 14, 2022
Transactions value $
$5,867,529
Form type
4
Date filed
2/17/2022, 05:00 AM
Previous filing
Jan 13, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +7.74K +20.61% $0.00 45.3K Feb 15, 2022 Direct F1
transaction JNJ Common Stock Tax liability -$558K -3.37K -7.43% $165.89 41.9K Feb 15, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Award $6.43M +38.7K $165.89 38.7K Feb 14, 2022 Common Stock 38.7K Direct F3
transaction JNJ Restricted Share Units Award $0 +3.92K $0.00 3.92K Feb 14, 2022 Common Stock 3.92K Direct F4
transaction JNJ Performance Share Units Options Exercise $0 -7.74K -91.31% $0.00 737 Feb 15, 2022 Common Stock 7.74K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Performance Share Units.
F3 Awarded under Issuer's Long-Term Incentive Plan.
F4 Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.
F5 Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.